Sugi Predict
/ Targets
/ DPM1
Top predicted compounds (top 20 by supporting neighbours, then confidence)
| Compound | Confidence | Supporting neighbours |
|---|
Clinical trials — most relevant to DPM1 by text similarity (a relevance ranking, not an exhaustive list)
| Trial | Phase | Status |
|---|
| A Multi-centre, Double-blind, Randomized, Vehicle-controlled Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO) |
PHASE3 | COMPLETED |
| 24-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Participants With PMM2-CDG |
PHASE2 | COMPLETED |
| Open-Label Extension Study to Assess GLM101 in PMM2-CDG Patients |
PHASE2 | ENROLLING_BY_INVITATION |
| Assessment of KM-001 - Safety, Tolerability, and Efficacy in Patients With PPPK1 or PC |
PHASE1 | COMPLETED |
| Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases |
PHASE1 | COMPLETED |
| Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidines |
PHASE1 | COMPLETED |
| A Study of the Tolerance, Safety, and Pharmacokinetics of GNR-055 in Healthy Volunteers |
PHASE1 | COMPLETED |
| Natural History Study Protocol in PMM2-CDG (CDG-Ia) |
nan | ACTIVE_NOT_RECRUITING |
| Glycosylation in Patients With Galactosaemia |
nan | COMPLETED |
| Using D-Galactose as a Food Supplement in Congenital Disorders of Glycosylation |
nan | COMPLETED |
| Genetic Identification (ID) of Segmental Dysplastic Nevi |
nan | WITHDRAWN |
| Biomarker for Mannosidosis Disease (BioMannosidosis) |
nan | WITHDRAWN |
| Biomarker for Hurler Disease (BioHurler) |
nan | WITHDRAWN |
| Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Population |
nan | COMPLETED |
| The Natural History of Alpha-Mannosidosis |
nan | COMPLETED |
| Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Blastomycosis Dermatitidis Infection in Patients Not Infected With HIV and Complications Associated With Blastomycosis Dermatitidis Infection |
nan | COMPLETED |
| Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network |
nan | RECRUITING |
| New Strategies of Genetic Study of Patients With Oculocutaneous Albinism |
nan | COMPLETED |
| Natural History Study of Mitochondrial Myopathy |
nan | RECRUITING |
| The Myelin Disorders Biorepository Project |
nan | RECRUITING |
| Clinical Genetics Branch Eligibility Screening Survey |
nan | NOT_YET_RECRUITING |
| IL-17 Role in Variants of Psoriasis |
nan | COMPLETED |
| A Long-Term Study of Cholesterol Supplements for Smith-Lemli-Opitz Syndrome |
nan | WITHDRAWN |
| Natural History of Individuals With Immune System Problems That Lead to Fungal Infections |
nan | RECRUITING |
| Natural History and Genetic Studies of Usher Syndrome |
nan | COMPLETED |
| Biomarker for Hypophosphatasia Disease (BioHypophos) |
nan | WITHDRAWN |
| Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines. |
nan | COMPLETED |
| Congenital Hemolytic and Dyserythropoietic Anemias |
nan | RECRUITING |
| The Nosology and Etiology of Leukodystrophies of Unknown Causes |
nan | COMPLETED |
| Exome Evaluation in Patients Living With Diabetes Complicated by Charcot Neuroarthropathy. |
nan | COMPLETED |
Related proteins — ESM-2 sequence neighbours (a DPM1 binder may also engage these)